Cost-Effectiveness of Intralesional Injection of Recombinant Human Epidermal Growth Factor for the Treatment of Severe Diabetic Foot Ulcers in Russian Health Care Setting
Abstract
Authors
V. Ignatyeva M. Avxentyeva G.R. Galstyan